Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immune suppression and tolerance. These pathways are now being identified and their relative contributions explored. Delineating how these pathways are interrelated is paramount to effectively implementing immunotherapy for GBM.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2Jp97FA
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου